Skip to main content
Menu
Revvity logo
Contact us

Loading...

US
Search all

Loading...

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Login/Register here
Revvity web shop online account

Get exclusive pricing on all online purchases.

Login to your Revvity.com account for your account's pricing, easy re-ordering from favorites & order history, priority order processing, and dynamic order tracking.

Login Register
Revvity Omics portal accounts

Initiate a new order or access test status and results for clinical genomics or newborn screening services.

View login options
Breadcrumb
...
  • Home
  • Explore automated DNA/RNA extraction for MRSA and GBS detection
Optimized-pathogen-detection-a-compatibility-evaluation-of-Revvity-chemagic-360-system-and-NZYTech-qPCR-Kits-for-MRSA-and-GBS
Application Note

Explore automated DNA/RNA extraction for MRSA and GBS detection

Automated nucleic acid extraction systems are essential in molecular diagnostic labs for efficient, reliable, and timely results. They reduce hands-on time, ensure consistency, and enable high-throughput processing of multiple samples simultaneously. Group B Streptococcus (GBS) and Methicillin-resistant Staphylococcus aureus (MRSA) are significant bacterial pathogens linked to healthcare-associated infections (HAIs) in vulnerable populations such as newborns, pregnant women, and hospitalized patients. Swift and precise detection of these pathogens is crucial for effective treatment and the prevention of HAIs, underscoring the importance of robust diagnostic methods in healthcare settings.

In this application note, we present the compatibility of the chemagic 360-D instrument and the chemagic™ Pathogen NA gDNA Kit H96 (IVD-1049) with the NZYTech™ qPCR Kits for MRSA and GBS detection.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.

Download Resource

Explore automated DNA/RNA extraction for MRSA and GBS detection

Download Application Note
Revvity Logo

Loading...

    ©2025 Revvity - All rights reserved

    Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.